© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
NYLI U.S. Large Cap R&D Leaders ETF (LRND) stock surged +1.09%, trading at $46.30 on NASDAQ, up from the previous close of $45.80. The stock opened at $46.25, fluctuating between $46.18 and $46.54 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 46.39 | 46.43 | 46.30 | 46.30 | 273 |
| Sep 10, 2026 | 45.79 | 45.87 | 45.79 | 45.80 | 1.08M |
| Sep 09, 2026 | 46.13 | 46.13 | 46.13 | 46.13 | 202 |
| Sep 08, 2026 | 46.35 | 46.35 | 45.91 | 46.35 | 7.46K |
| Sep 04, 2026 | 46.63 | 46.63 | 46.63 | 46.63 | 137 |
| Sep 03, 2026 | 46.36 | 46.76 | 46.36 | 46.76 | 2.02K |
| Sep 02, 2026 | 46.19 | 46.19 | 46.19 | 46.19 | 319 |
| Sep 01, 2026 | 45.94 | 45.94 | 45.94 | 45.94 | 16 |
| Aug 31, 2026 | 46.29 | 46.45 | 46.29 | 46.44 | 10.12K |
| Aug 28, 2026 | 46.55 | 46.58 | 46.55 | 46.58 | 146 |
| Aug 27, 2026 | 46.64 | 46.90 | 46.64 | 46.90 | 137 |
| Aug 26, 2026 | 46.06 | 46.06 | 45.97 | 45.97 | 122 |
| Aug 25, 2026 | 46.17 | 46.29 | 45.95 | 46.09 | 3.49K |
| Aug 24, 2026 | 45.83 | 45.91 | 45.83 | 45.84 | 761 |
| Aug 21, 2026 | 45.98 | 46.20 | 45.98 | 46.20 | 146 |
| Aug 20, 2026 | 46.11 | 46.16 | 45.95 | 45.97 | 1.78K |
| Aug 19, 2026 | 46.25 | 46.35 | 46.25 | 46.30 | 372 |
| Aug 18, 2026 | 46.23 | 46.35 | 46.23 | 46.30 | 0 |
| Aug 17, 2026 | 47.16 | 47.16 | 46.84 | 46.85 | 2.08K |
| Aug 14, 2026 | 47.00 | 47.05 | 47.00 | 47.05 | 388 |
New York, NY 10010
United States
https://www.nylim.com/etf/nyli-us-large-cap-rd-leaders-etf-lrnd180 062 46782The NYLI U.S. Large Cap R&D Leaders ETF (LRND) aims to replicate the total financial return—encompassing both capital gains and income generation—of the NYLI U.S. Large Cap R&D Leaders Index, prior to the deduction of any fees or expenses. This underlying index is designed to provide investment access to groundbreaking companies by focusing on large-capitalization U.S. equities from firms renowned for their sustained and impactful investment in research and development initiatives.
| Employees | 0 |
| Beta | 1.07 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Financial Services |
| Industry | Asset Management |